YN
Yigal Nochomovitz Citigroup Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
71
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
82.4%
Neutral
11.8%
Negative
5.9%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $22 |
245%
upside
| 1 | +2.5% |
0
%
| 13 Mar ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $7 |
7%
downside
| 2 | – |
–
| 13 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $9 |
12%
upside
| 1 | +34% |
0
%
| 11 Mar ‘26 1 month ago |
|
|
|
Sell
Maintained
| $9 |
58%
downside
| 1 | -14% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $2.30 |
23%
upside
| 1 | +23% |
0
%
| 10 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $35 |
134%
upside
| 1 | -14% |
0
%
| 9 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $33 |
11%
upside
| 1 | +14% |
0
%
| 6 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $45 |
86%
upside
| 1 | +17% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $18 |
64%
upside
| 2 | +6.6% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Neutral
Maintained
| $8 |
10%
downside
| 2 | +1.3% |
0
%
| 4 Mar ‘26 1 month ago |
|
|
|
Buy
Initiated
| $42 |
68%
upside
| 1 | +3.1% |
0
%
| 3 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $57 |
135%
upside
| 1 | +60% |
0
%
| 2 Mar ‘26 1 month ago |
|
|
|
Buy
Maintained
| $44 |
8%
upside
| 1 | +2.4% |
0
%
| 25 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $17 |
58%
upside
| 1 | +0.14% |
0
%
| 24 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $65 |
92%
upside
| 1 | +12% |
0
%
| 19 Feb ‘26 1 month ago |
|
|
|
Buy
Maintained
| $371 |
35%
upside
| 4 | +0.97% |
0
%
| 18 Feb ‘26 2 months ago |
|
|
|
Buy
Maintained
| $204 |
53%
upside
| 1 | -2.4% |
0
%
| 12 Feb ‘26 2 months ago |
|